Literature DB >> 8165722

Antisense oligonucleotide strategies in neuropharmacology.

C Wahlestedt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8165722     DOI： 10.1016/0165-6147(94)90107-4

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  44 in total

1.  Potent and nontoxic antisense oligonucleotides containing locked nucleic acids.

Authors:  C Wahlestedt; P Salmi; L Good; J Kela; T Johnsson; T Hökfelt; C Broberger; F Porreca; J Lai; K Ren; M Ossipov; A Koshkin; N Jakobsen; J Skouv; H Oerum; M H Jacobsen; J Wengel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory.

Authors:  J F Guzowski; G L Lyford; G D Stevenson; F P Houston; J L McGaugh; P F Worley; C A Barnes
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

3.  Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance.

Authors:  Y A Kolesnikov; Y X Pan; A M Babey; S Jain; R Wilson; G W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 4.  DNA antisense strategies in the study of receptors for vasoactive peptides, and of growth and wound-healing factors.

Authors:  P D'Orléans-Juste; M G Sirois; E R Edelman; D Regoli; L H Pheng; G Bkaily; C J Lindsey
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

5.  Evidence from immunoneutralization and antisense studies that the inhibitory actions of glucocorticoids on growth hormone release in vitro require annexin 1 (lipocortin 1).

Authors:  A D Taylor; H C Christian; J F Morris; R J Flower; J C Buckingham
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

6.  A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain.

Authors:  Mahesh M Thakkar; Stuart Winston; Robert W McCarley
Journal:  J Neurosci       Date:  2003-05-15       Impact factor: 6.167

7.  Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides.

Authors:  J A Hughes; A I Aronsohn; A V Avrutskaya; R L Juliano
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

8.  Inhibition of the NGF and IL-1beta-induced expression of Alzheimer's amyloid precursor protein by antisense oligonucleotides.

Authors:  K A Chang; S H Kim; Y Sakaki; H S Kim; C W Park; Y H Suh
Journal:  J Mol Neurosci       Date:  1999-02       Impact factor: 3.444

9.  Molecular mechanisms regulating NGF-mediated enhancement of cholinergic neuronal phenotype: c-fos trans-activation of the choline acetyltransferase gene.

Authors:  J L Pongrac; R J Rylett
Journal:  J Mol Neurosci       Date:  1998-08       Impact factor: 3.444

Review 10.  Application of antisense DNA method for the study of molecular bases of brain function and behavior.

Authors:  S Ogawa; D W Pfaff
Journal:  Behav Genet       Date:  1996-05       Impact factor: 2.805
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.